Misc

This is an information request relating to Pride month 2025

Please include the following information:
Whether any events have been organised for Pride month. If so please provide the date, start and end time, and title/topic of the event
Whether any LGBT themed merchandise has been purchased for Pride month. i.e. since the beginning of the 2025/26 financial year. If so please provide me with information on what has been purchased and the cost
Whether the organisation have sponsored any Pride events. If so which events and please provide details of the nature of the sponsorship (particularly the financial value)

I am writing to request information under the Freedom of Information Act 2000 regarding the implementation and evaluation of Family Integrated Care (FICare) within your neonatal services.
Please could you provide the following:
1. Confirmation of whether Family Integrated Care (FICare) is currently implemented in your neonatal unit(s), and if so, the date of initial implementation.
2. Copies of any internal policies, protocols, or guidance documents relating to FICare.
3. Details of any staff training programmes or materials used to support FICare delivery.
4. Details of any staff training programmes or materials used to support FICare delivery relating to older siblings.
5. Any audit reports, evaluations, or outcome data relating to the effectiveness or impact of FICare on neonatal care or family experience.
6. If FICare is not currently implemented, please indicate whether there are plans or discussions underway to introduce it.

In addition (and if relevant), please could the Trust provide information on its policies or regulations regarding parental and sibling access to babies receiving neonatal care:
1. Are both parents and siblings permitted to spend time with babies in neonatal care units?
2. Are there any time restrictions or limitations on how long parents or siblings may spend with babies in neonatal care?
3. Does the Trust have any policies to ensure that babies from multiple births (e.g. twins, triplets) receive equal parental contact time compared to singleton babies?

Under the Freedom of Information Act I am requesting the following information from the trust:

1. The number of harm reviews carried out on lung cancer patients who faced lengthy waits for treatment between 1 January 2023 and 31 December 2024 (please do not include incomplete reviews)
2. The number of cases where harm was found in lung cancer patients and the level of harm in each: e.g, low harm, medium harm, severe harm
3. In lung cancer cases where there was severe harm, please provide a short but specific description of what the harm was: e.g. stage migration, patient moved straight to palliative care etc;
4. After how many days does the trust initiate harm reviews of lung cancer patients that have faced lengthy waits for treatments? (please state a number and do not include links to policies)

I am a freelance journalist looking into maternal healthcare in UK health trusts and boards a year on from a report by the All-Party Parliamentary Group on Birth Trauma.

I would be grateful for responses by email to the following 13 questions, which I am sending to every UK non-specialist health trust and board.

I appreciate it is a long list of questions, and it’s quite possible not all of them will be relevant to your organisation. I also appreciate that data going back 10 years will not always be available, as your organisation may have been formed more recently than that. In this case, I would be grateful for the data stretching back as far as is possible.

1. How many vacancies do you currently have for a) midwives; b) obstetricians? (And how many members of staff do you currently have in both those roles?)
2. What is the number of stillbirths and neonatal deaths recorded in your trust/board in each of the past 10 years? And what was the recorded ethnicity of those who died, if the data is available?
3. How many live births were recorded at your trust/board in each of the past 10 years?
4. What is the number of maternal deaths recorded in your trust/board in each of the past 10 years? And what was the recorded ethnicity of those who died?
5. How many medical negligence suits have arisen from incidents in your maternity department in each of the past 10 years? How many resulted in a payment being made, and how much was paid out in each of the past 10 years?
6. How many third- and fourth-degree tears have you recorded for each of the past 10 years?
7. What are your current rates of forceps use, if you keep data on this?
8. What are your current rates of ventouse assisted deliveries, if you keep data on this?
9. How many emergency caesarean sections have you carried out in each of the past 10 years?
10. How many Maternal Request Caesareans were made to staff in each of the past 10 years and how many were approved?
11. How much did your trust/board pay for use of interpreters in its maternity department in each of the past 10 years?
12. How many people have received treatment as part of any MMHS (Maternal Mental Health Service) in the past year?
13. How many people are on the waiting list to receive treatment from the MMHS right now? And how long is the average waiting time for treatment?

I am writing to you under the Freedom of Information Act 2000 to request the following
information from Gloucestershire Health and Care NHS Trust relating to Continence and Stoma
Care agreement(s) for nurse sponsorship.
1. Do you have Continence and/or Stoma sponsorship agreement (or agreements) in place
across your Trusts’ different hospital sites? If your hospital sites have different
agreements please answer the below questions separately.
2. We appreciate some agreements span Acute, Community, Mental Health and Primary
Care Service providers. Which NHS organisations and/or hospital sites is this applicable
too?
3. When was it launched and when will it be up for renewal?
4. Who is the provider?
5. Across the full contract length, what is the value?
6. Can you share the procurement notice?
7. How many nurses were provided? If yes, what band and FTE?
8. Are their honorary contracts provided? If yes, what band and FTE?
9. What other incidentals were included in the tender? Including but not limited to; training,
IT, vehicles, grants, travel etc
10. What KPIs are included in the agreement and how is success measured?

Could you please assist me with some information regarding your SAR & FOI processes and similar requests for information.

1) Could you please supply a copy of your SOP, process and/or policies for processing SARs and FOIs.

2) When receiving forms from DWP, adoption forms, individuals wanting a supporting cover letter outlining their diagnosis or identified struggles, for an application for additional charitable support or for employment etc, (a) who completes these?
2b) What is your process and policy for these types of requests? please provide any SOP or process you follow.

3) What department/who processes the requests for S117 information?

4) What department/who processes requests for section papers and providing recent progress notes from representing solicitors?

5) How many people are employed to process information requests? Please break this down by SARs and FOIs. What is the WTE?

6) How many SARs were processed by your trust in 2024(Jan-Dec)? what was the compliance for these requests, please break down by month.

7) How many FOIs were processed by your trust in 2025 (Jan – Dec)? what was the compliance for these requests, please break down by month.

In accordance with the Freedom of Information Act, please can you answer the following questions

• Who is the Clinical Lead for Neurodevelopmental Services? What is their email address?
• Who is the Service Manager for Neurodevelopment Services? What is their email address?

Under the Freedom of Information Act 2000, please provide the following information about your procurement of any
(i) external Data Protection Officer (DPO),
(ii) Data protection GDPR compliance services for the period FY2022-23 to FY2024-25:

1.⁠ ⁠Current DPO arrangements
1.1 Is the organisation’s DPO and other staff that work on data protection
compliance:
(a) An internal employee
(b) A DPO provided by an external service provider
(c) Hybrid (internal staff with external service provider support)
1.2 Where services are provided by external providers, please share the following information:
(a) The Company name(s)
(b) Annual spend by your organisation (FY2022/2023 through to
FY2024/2025)
(c) The highest day rate paid
(d) Contract dates (start/end/renewal terms)
(e) A brief description of the project or services provided (for instance, project title or internal reference)
(f) Services covered (e.g., audits, breach management, SAR management, delivery of DPIAs) •⁠ ⁠Please indicate what deliverables were produced •⁠ ⁠Procurement method (e.g., open competition, framework agreement, direct
award) and name of the procurement framework, if applicable.

2.⁠ ⁠Consultancy Spend
2.1 What is the organisation’s, total annual expenditure on data protection/GDPR consultancy services?

2.2 For SoW/projects which have a spend of more than £5k), please share the following information:

•⁠ ⁠Supplier company name
•⁠ ⁠The scope of the Project (e.g., "ICO investigation support", DPIA support, Internal Audit recommendation support) •⁠ ⁠Spend •⁠ ⁠Procurement method

3.⁠ ⁠Data Protection Compliance staffing
3.1 The Number of in-house data protection staff in the organisation?
(FTE)
3.2 Are there any vacant roles? (Yes/No)
3.3 Where there any ICO investigations, audits, or enforcement actions for the period from FY2022/2023 to FY 2024/2025?

4.⁠ ⁠Future Plans
4.1 Is your organisation planning to put out to tender for any DPO/GDPR services in the current financial year?
4.2 If yes please provide the following:
Expected timeline
Budget range
Key service requirements
Procurement method

Under the Freedom of Information Act I would like to request the following information.

The request relates to home enteral tube feeding, which is a way of providing nutrition to people who can’t eat and drink normally. Dietitians within your organisation will likely be best placed to help with this information request.

1. Does your organisation provide care to individuals aged 0-25 who may use home enteral feeding tubes? Yes/No
2. How many patients has your organisation provided dietetic care for home enteral tube feeding between 01-01-2023-31-12-2024?
a. Divided into the following age categories: 0-18, 18-25, 25+ (age when they joined the caseload or age on 01-01-23 if they were on the caseload throughout this period).
b. If possible, please provide caseload numbers by age (e.g. <1, 1-2, 2-3... years etc.) 3. Of these, how many individuals use a blended diet*? a. Divided in the following age categories: 0-18, 18-25, 25+ b. If possible, please provide caseload numbers by age (e.g. <1, 1-2, 2-3... years etc.) 4. Does your organisation have the following: a. Local blended diet policy – Acute setting (Yes/No) b. Local blended diet policy – Community setting (Yes/No) c. Blended diet guideline (Yes/No) d. Blended diet standard operating guideline or procedure (Yes/No) e. Blended diet training package (Yes/No) f. If yes to 4a-4e, please provide a copy. 5. Are any staff employed by your organisation in roles funded by income provided by an enteral feeding provider (e.g. Nutricia, Abbott)? a. If yes, please state number of posts (whole time equivalent) and Agenda for Change banding. b. *A blended diet is the use of everyday foods blended to a puree and given via an enteral feeding tube. This may be used exclusively or in combination with commercial formula.

I am writing to make a request under the freedom of information act 2000. I write to request information about the Trust’s relationship with the company that produces Bounty packs, which are handed out to expectant / new parents accessing NHS maternity services, and specifically to ask:

– Whether the Trust currently allows, or previously allowed, Bounty representatives on its wards, and if so, when this began / ended;
– Whether the Trust currently distributes or allows the distribution of Bounty packs to expectant parents and / or new mothers, and if so, which Bounty packs are distributed, how (e.g. by midwives / by Bounty representatives), and the approximate number of packs supplied by Bounty to the Trust each year;
– Whether the Trust has any financial relationship involving the payment or receipt of funding or support from Bounty UK or its affiliates / partners (Bounty Group Ltd, Joy Memories Inc) in relation to the distribution of Bounty packs or other services from Bounty, and if so, what such payment/support relates to, when such payments/support began, the total £ value received to date and the £ value of any current contract;
– Copies of any contracts, agreements or memorandums of understanding with Bounty (or its parent company or affiliates, including Bounty Group Ltd, Bounty UK Ltd, or Joy Memories Inc.) in relation to the distribution of Bounty packs or other services from Bounty;
– Whether the trust has received any assurances from Bounty in relation to data protection, and if so, the nature of these assurances;
– Whether the Trust has ever received any complaints about Bounty UK and if so, the numbers and nature of complaints over the period received.

Under the Freedom of Information Act 2000 I would like to request the following information from the trust from the last five financial years:
1. The number of staff who were sent to a foreign country to facilitate recruitment drives (to address shortages as set out as part of the NHS Long Term Plan).
2. The total cost to the trust of each recruitment drive exercise including flights and accommodation
3. The city and country that were visited as part of the exercise
4. The type of staff it was hoped would be recruited
Please can the information be broken down by year, for the last five financial years (2020/21, 2021/22, 2022/23, 2023/24, 2024/25)
Please limit the search to just those where the bills for the recruitment were paid in any of the last five financial years.

I am writing to you under the Freedom of Information Act 2000 to request the following information from Gloucestershire Health and Care NHS Foundation Trust. Please may you provide me with the information for the following:

1. Testing and Management Protocols for Carbapenem-Resistant Enterobacteriaceae (CRE)

1.1. Does your trust have a clinical protocol for testing and managing patients for Carbapenem-Resistant Enterobacteriaceae (CRE)?

If yes:
a) Is your CRE testing protocol primarily molecular-based?
b) If not, please specify which type of testing protocol is followed.

1.2. Which diagnostic companies or providers does your trust procure molecular testing kits for services for CRE from?

2. Testing Protocols for Clostridioides difficile (C. difficile) Infection

2.1. Does your trust have a formal protocol for testing patients for Clostridioides difficile (C. difficile) infection?

If yes:
a) Is your C. difficile testing protocol molecular-based?
b) If not, please specify the testing method used.

2.2. Which diagnostic companies or providers does your trust procure molecular testing kits for services for C. difficile from?

3. Testing and Procurement for Tuberculosis (TB) Resistance

3.1. What methods does your trust use to test for tuberculosis (TB) resistance?
3.2. Which diagnostic companies or providers does your trust procure molecular testing kits for services for TB resistance from?

We are a law firm and act for Health Workers 4 Palestine (“HW4P”), a private company limited by guarantee (Company number: 15544250). HW4P advocates for the rights of Palestinian health workers, and its aims include ensuring that healthcare workers are protected and supported globally during humanitarian crises and armed conflict.

The purpose of this letter is to submit a FOIA request on HW4P’s behalf, expeditious compliance with which is necessary for its vital work.

Request for Information

1. Please disclose any correspondence received by your organisation (including by your chief executive) in the last 6 months from NHSE regarding (i) uniform policy, (ii) use of political symbols by NHS staff.

2. Please disclose any new uniform policy for your organisation from the last 6 months, including policies which are in draft and not yet published or implemented.

I wish to make a freedom of information request and would be grateful if you could supply the following information within twenty working days:

The number of patients processed by your Trust between the years 2018 and 2025 who were classified as having a chargeable status.

The number of individuals in receipt of secondary care who, under the ‘NHS Charges to Overseas Visitors Regulation, 2015’ were classified as “Charging Category F”.

The total value of the treatment provided to those individuals who were classified as falling under “Charging Category F”.

Please also confirm whether your Trust has an Overseas Visitor Manager position(s), the total number, and whether all roles are presently filled.

I am writing under the Freedom of Information Act 2000 to also request the following information:

1. The number of patients referred to your Trust for Overactive Bladder (OAB) in each of the past five calendar years, from 2020 to 2025 (year to date). Please include both internal referrals within the Trust and external referrals from primary care or other organisations.

Please provide the information broken down by calendar year.

2. The number of patients treated for OAB using each of the following modalities in each calendar year from 2020 to 2025 (year to date):
a. Intradetrusor botulinum toxin (Botox) injections
b. Sacral nerve stimulation (SNS) or tibial nerve stimulation (TNS)

Please provide this data broken down by year and treatment type.

If available, please also include whether any patients received both treatments concurrently or sequentially.

We are writing on behalf of the trustees of C diff Trust (Charity Commission no.1210298), a new charity to support patients, carers and healthcare professionals to recognise and manage C. difficile infections.

Under the Freedom of Information Act, please can you tell us:

What information material do you provide to patients diagnosed with C. difficile infection in your care?

If possible, please provide either the material or a link to this information if available?

I am emailing to submit a Freedom of Information (FOI) request regarding your Trust’s estate and infrastructure. Please find all relevant questions in the attached document.

I was hoping you could answer the following queries in relation to provision of Transcranial Magnetic Stimulation (TMS).

1. Does the Trust provide TMS to patients in its own TMS clinics?

2. In the last 24 months, has the Trust funded TMS for any patients in external (private or neighbouring NHS) clinics?

I am requesting this information under the Freedom of Information Act.
1. How many hospital admissions in the past five years had the recorded reason for attendance of ‘food poisoning’? Please provide figures for the financial years 2020/21, 2021/22, 2022/23, 2023/24 and 2024/25.
Note: If it is not possible to provide a response for ‘food poisoning’ specifically, please include all admission codes under which a food poisoning-related admission could be logged.
2. How many reported admissions in total involved the following?:
2a. Salmonella
2b. E.Coli
2c. Campylobacter
For 2a, 2b and 2c, please also provide a breakdown by financial year (same years as in Q1)
If possible, please provide a breakdown of the foodstuffs stated as the cause of the illness.

I request all information, including directions to staff concerning new policies, regarding the response to the supreme courts clarification in the Vs Women’s Scotland, which clarified that the word woman in the Equality act 2010 means Adult Human Females and sex refers to biological sex. I particularly request any guidance provided to locations such as hospitals, GPs and any treatment centres with regard to single sex services, information regarding the provision of facilities such as toilets, locker rooms, changing facilities and who has access to them, and any disputes having arisen from policies being single sex only.

I request any documentation on policy after the ruling in April 25 that deals with these issues or details plans to go against the law and plans to allow men to enter women only spaces or access to single sex women’s services. I also request any directive or documents that have mentioned needing further clarification from the EHRC.

The University of Liverpool’s Civic Health Innovation Labs, as part of the Liverpool City Region’s Health and Life Science Innovation Zone, has commissioned a UK-wide landscape mapping study to better understand the current state of extended reality (XR) in healthcare. This research is being led by the XR Health Alliance, in collaboration with the University of Nottingham’s Mindtech, and will culminate in an interactive online report. This report aims to identify and showcase the breadth of XR-related research, development, and deployment across physical and mental health applications in the UK. It will serve as a valuable tool to help foster collaboration, shape future grant programmes, and support sector-wide growth and innovation.
The questions for this Freedom of Information request and further information can be found in the attached Word Document.

Under the Freedom of Information Act, please could I request the following information from your trust:

1. In your organisation, do you employ “job planning” for pharmacists (job planning in this instance is typically the division of a working week into half day “sessions” allocated to commitments such as clinical work, development, supporting professional activities time, teaching, research, etc)?

2. How many pharmacists do you employ? Please state headcount

3. Of the pharmacists that you employ, how many have job plans?

4a. For each pharmacist with a job plan, please provide the proportion of contracted hours allocated to protected* time for supporting professional activities (SPA), also known as protected learning time or professional development time

4b. For each pharmacist without a job plan, please provide the proportion of contracted hours allocated to protected time for supporting professional activities (SPA), also known as protected learning time or professional development time

5. If it is not possible to provide an answer to question 4a or 4b, please provide the recommended allocation to supporting professional activities (SPA), also known as protected learning time or professional development time, in hours per week for a full-time employed pharmacist.

*For the purposes of this FOI request, protected is defined as a time allocation that should be uninterrupted and dedicated to non-mandatory training and development, although this may not always be the case.

I am writing to request the following information under the Freedom of Information Act 2000.
1. How many staff members currently employed by Gloucestershire Health and Care NHS Foundation Trust have declared a disability via the Electronic Staff Record (ESR) or any other internal systems?
2. Of these, how many are:
o Issued a Purple Passport (or equivalent), or
o Have been granted reasonable adjustments ?
o How many Purple passport holders have long covid if any ?
3. Does the Trust operate a Purple Passport scheme (or similar system) to support disabled staff in accessing adjustments? If so, please provide a brief description.of what adjustments have been granted and indicate numbers gaining this status

We would ask for your NHS Trust to provide information on two aspects:

1. Whether safety screening forms or checklists which are completed by patients prior to a diagnostic imaging examination are in paper form or in digital format (e.g. web-based or tablet)?
This includes but may not be limited to:
• Inclusive Pregnancy status (IPS) or last menstrual period (LMP) forms
• Magnetic resonance imaging (MRI) safety forms
• Contrast media administration (all modalities)
• Bone densitometry (DXA) patient questionnaire
• Any other examination-specific forms e.g. CT colonography or cardiac questionnaires.

2. If any of these are completed in paper form, we would ask for a copy of the current version to be sent via email.

We do not require information regarding staff completed forms e.g. WHO safety forms however, we would request that forms initially completed by a patient and co-signed by a staff member at the time of the examination are included.

The information is being sought to compare practice across Trusts.

I am writing to update and clarify my request for information under the Freedom of Information Act 2000.
The purpose of this request is to gather data on overnight Minor Injuries wait times within the trust.
Specifically, I am seeking anonymised data on the following:
1. How many patients in Minor Injuries waited 24 hours or more from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
2. How many patients in Minor Injuries waited for 3 hours or more between the hours of 11pm-6am from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
3. The average Minor Injuries wait time from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
If you are unable to provide the specified information:
• If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
• If you are unable to provide the specified information exactly as requested, please provide *any* data you have that is relevant to the request, e.g. 2024 only, and explain why the other information cannot be provided.

I am writing to request information under the Freedom of Information Act 2000 concerning the handling and storage of deceased persons at your hospital’s mortuary.
This request is being made to all NHS hospitals with mortuary facilities located in the UK. I would be grateful if you could provide the following information for your hospital for the most recent 24-month period available:
1. The average length of time deceased individuals are kept in your hospital mortuary prior to release for burial or cremation.
2. The minimum and maximum duration any deceased individual was retained in your mortuary during that period.

3. The total number of deceased released from your mortuary, broken down by:
– Online funeral directors (those primarily operating through online platforms)
– Local/traditional funeral directors (those with a physical local presence)

4. The average duration of stay in your mortuary for deceased individuals handled by:

– Online funeral directors
– Local funeral directors

5. The total number of requests for jewellery to be removed, broken down by:

– Online funeral directors (those primarily operating through online platforms)
– Local/traditional funeral directors (those with a physical local presence)

6. The total number of requests for the deceased to be dressed for viewing in the mortuary, broken down by:

– Online funeral directors (those primarily operating through online platforms)
– Local/traditional funeral directors (those with a physical local presence)

If applicable, I would also appreciate it if you could share any internal protocols or policy documents regarding the standard retention period for deceased individuals in your care.

I am making a FOI request in respect of the referral criteria for the Community Learning Disability Team (CLDT), Gloucestershire.

I am writing to request information under the Freedom of Information Act (2000).
I would be most grateful if you could please provide details on the use of Minimally Invasive Cancer Therapies (MICTs), commissioned or delivered within your Trust area during the 2024-2025 financial year. The types of treatments MICTs include are:
• Cryoablation
• Selective Internal Radiation Therapy (SIRT)
• High-Intensity Focused Ultrasound (HIFU)

Please confirm if your Trust does or does not commission any of these procedures. If so, please list the therapies involved.
In addition, if your Trust carry out any of these procedures, I would be most grateful if you could please provide me with details of the number of times each therapy was used or delivered within the 2024 – 2025 financial year.
To summarise, I am requesting the following:
1. Does your trust commission and/or deliver any of the following MICTs: Cryoablation, Selective Internal Radiation Therapy (SIRT) and High-Intensity Focused Ultrasound (HIFU)? If yes, which therapies?
2. For each therapy commissioned or delivered, how many times was it used or delivered within the 2024-2025 financial year?

I would like to make a freedom of information request for the following:

The number of mentally unwell people in your care that have died from diabetes complications from 2014 – 2024. If you do not have these records then please direct me to the government department that does if possible.

I would be very grateful for your time and support with providing the below information.

Information requested:

1. Does your Trust provide mental health services for:
o Adults (18+)?
o Children and adolescents (under 18)?

2. Please provide a brief overview of the services provided to Adults
3. Please provide a brief overview of services provided to Children

4. Please provide the number current number of employees

5. Please provide your organisations safeguarding team structure, including Executive, Named Dr’s, all statutory and non-statutory roles and admin support including:

Job titles (specifying adults and or children), MCA and Prevent etc
Please include Grade

Please can you kindly share
Whether the safeguarding function is managed centrally or across individual service areas
What the safeguarding team duties include
Do you provide Looked After Children services?
Is the LAC team part of the safeguarding team?

Who is the lead for implementing sexual safety? (job title and directorate)

Who is the lead for managing allegations against staff? (job title and directorate)

Who manages the child protection invites i.e. centrally, operational teams, safeguarding etc?

Data:

Please could you kindly share the following data

Safeguarding Adults

· Total number of Safeguarding Adult referrals made to the local authority per quarter from Q1 2024 through to Q4 2025
· Total number of referrals by Care Act category of abuse per quarter from Q1 2024 through to Q4 2025
· Total Number of Prevent Referral Q1 2024 through to Q4 2025
Total Number of Allegations against staff referred to the local authority between April 2024 to March 2025
Total Number of allegations against staff managed internally between April 2024 and March 2025

Safeguarding Children

· Safeguarding children referrals made to the local authority per quarter from Q1 2024 through to Q4 2025
· Referrals by Children Act category of abuse per quarter from Q1 2024 through to Q4 2025
· Total Number of Children Early Help referrals per quarter from Q1 2024 through to Q4 2025
· Total Number of Prevent Referrals Q1 2024 through to Q4 2025
Total Number of Allegations against staff referred to the LADO between April 2024 to March 2025
Total Number of allegations against staff managed internally between April 2024 and March 2025

Child Protection Engagement Data

· Total % of engagement (attendance or report) with Children protection Initial Case Conferences per Quarter Q1 2024 through to Q4 2025
Please clarify the % proportion of attendance per quarter
Please clarity the % proportion of reports send instead of attendance

· Total % of engagement with Review Child Protection Conferences per Quarter
Please clarify the % proportion of attendance per quarter
Please clarity the % proportion of reports send instead of attendance

Domestic Homicide Review, SAR’s and Rapid Reviews

Total Number of DHR’s which the organisation has contributed to April 2024 to March 2025
Themes of DHR’s in this time frame

Total Number of SAR’s which the organisation has contributed to April 2024 to March 2025
Themes of the SAR’s in this time frame

Total Number of Rapid Reviews which the organisation has contributed to April 2024 to March 2025
Themes of the RR in this time Frame

Training

Do you delivery DASH training? Are your trainers accredited?

Please provide training compliance as of Q4 2025 for the below:

Children Safeguarding Level 1
Children Safeguarding Level 2
Children Safeguarding Level 3
Adults Safeguarding Level 1
Adults Safeguarding Level 2
Adults Safeguarding Level 3
Prevent
MCA

I am writing to request information on vegan options. I request the information below under the Freedom of Information Act 2000.

Freedom of Information Request
1. Have you undertaken an equality impact assessment for vegans at the NHS? If yes, can you provide a copy of the assessment?

2. Are you following your public sector equality duty toward vegans? Please provide any documents or information to explain whether and how the PSED is being followed towards vegans.

3. Do you guarantee a full vegan option that is nutritionally appropriate on all NHS menus and cafeterias at all times, for all meals, including breakfast, lunch, dinner and snack options. By ‘guaranteed’ I mean, is there always a fully vegan option available.

For clarity, a salad without a plant-based protein and starch or carbohydrate would obviously not be nutritionally appropriate, nor would having only fruit or toast with jam available for a vegan person. For example, many vegetarian options adapted to be vegan would not be nutritionally appropriate as they would be lacking in protein unless there was a substitution provided.

4. Do you guarantee plant milk availability on all NHS campuses for coffee and tea? For clarity, plant milk refers to: Soy, oat, almond, or coconut milk.

I am a journalist working for BBC Radio 4, writing to request information under the Freedom of Information Act 2000
On 15 February 2023, the Medical and Healthcare Regulatory Agency (MRHA) issued a notice advising of the withdrawal of all All NexGen Complete Knee Solution Stemmed Nonaugmentable Option Tibial Components made by Zimmer Biomet.
This was followed by an MHRA notice issued on 15th February 2023 stating that there was a higher revision rate for NexGen knee replacements compared to other knee replacements.
They identified the NexGen® Stemmed Option Tibial Components when paired with either the Legacy® Posterior Stabilized (LPS) Flex Option Femoral or the LPS Flex Gender Solutions Femoral (GSF) Option Femoral.
The MHRA advised the patients should be offered additional follow-up.
I would like to request the following information under the Freedom of Information Act 2000
From the 15th February 2023 until 13 June 2025:
1. How many patients has your Trust identified that have been implanted with the affected devices?
2. How many of these patients have been notified about this recall?
3. How many of these patients have received a follow up consultation?
4. How many of these patients have received revision surgery?
5. How many of these patients are awaiting revision surgery?

Under the Freedom of Information Act 2000, I would like to request the following information relating to your organisation’s use of learning technologies and associated services.
1. Current Learning Management System (LMS)
a. What Learning Management System (LMS) or e-learning platform(s) does your organisation currently use?
b. If Totara or Moodle is in use, please confirm which version is currently implemented.
c. What is the LMS primarily used for (e.g. internal staff development, compliance training, onboarding, external learner access, apprenticeship delivery)?

2. Contract and Provider Details
a. Who is your current LMS support, hosting, or implementation provider?
b. What is the value of your LMS-related contract per annum?
c. What is the contract start and end date (including any optional extension periods)?
d. Please confirm if the LMS is hosted on-premise, via a private cloud, or through a SaaS model.
3. Procurement and Decision-Making
a. What is the name and role of the person responsible for the learning platform and/or digital learning strategy?
b. What is the name and role of the commercial contact responsible for LMS procurement or renewals?

4. Planned Changes or Reviews
a. Are there any plans to review or replace your LMS in the next 12–24 months?
b. Are there any scheduled or anticipated procurement events or tenders related to learning, compliance, or workforce development systems?

5. Integration and Strategic Use
a. Is your LMS currently integrated with other internal systems (e.g. HRIS, payroll, CRM)?
b. Are there strategic goals linked to digital learning, compliance reporting, or learner engagement which the LMS is expected to support?

I am writing to request the following under the Freedom of Information Act, regarding use of and provision for the DASH checklist, aka Domestic Abuse, Stalking and Honour Based Violence

1. Is the DASH RIC used by your organisation as part of services (e.g. domestic abuse provision, victim support)?
2. Is the use of DASH RIC a standard provision or a requirement in contracts with third-party providers of relevant services (e.g. domestic abuse services, sheltered housing)?
3. If the DASH checklist is used by your organisation, which organisation or organisations provide the training that includes DASH training? (e.g. Domestic Abuse Matters training)
4. What is the cost to your organisation of such training? Please break this down by financial year over the last five years, as well as by organisation (if more than one organisation provides the relevant training)

Please provide the following information, Any and all annual data on record to the present day.

1. How many patients have been referred to the trust and presented for the treatment of BRUXISM (Grinding of the teeth)?

2. Please provide geographical date in regards which hospital the patients presented to.

3. Annual cost to the trust and its subsidiaries.

Does the Trust have a staff policy in respect of the wearing/use of fragranced products? Please provide a copy of your staff policy concerning the wearing/use of fragranced products (including use of fragranced laundry products). Where terms such as ‘overwhelming’, ‘overpowering’ or ‘discreet’ are used in respect of fragrance, how are these terms defined and who decides if the level of scent contravenes the guidance: the wearer, the Trust or the patient? How is the policy brought to the attention of staff? Is the policy in respect of the wearing of fragranced products enforced? How is it enforced? What training is given to staff to make them aware that the use of fragranced products can be an accessibility barrier for patients? Please provide details. If any such material is third party copyrighted, please provide a synopsis. Please provide copies of any correspondence, memos or minutes of meetings pertaining to discussion of the use of/ wearing of fragranced products by staff, including use of fragranced laundry products to wash clothing worn at work.

In accordance with the Freedom of Information Act, could you kindly confirm the name of your Trust’s Integration Engine?

I am writing to request information under the Freedom of Information Act 2000.
After reviewing your website and other publicly available information, I have not been able to identify the appropriate contact details for third parties (such as suppliers or service providers) to send formal legal correspondence to your organisation.
Please could you confirm the following:
1. Whether your organisation has one or more specific teams, departments, or named individuals responsible for receiving formal legal correspondence from third parties.
2. The relevant postal address(es), email address(es), and telephone number(s) that such correspondence should be directed to. If responsibility differs by type of issue (e.g. contractual, procurement-related, legal) or by region, please provide the details for each as applicable.
3. If this information is already published, please confirm where it can be found.
This request is made in the public interest to ensure there are clear and transparent routes for formal engagement with public authorities.

I wish to make a freedom of information request and would be grateful if you could provide the following information within 20 working days:

a) The number of staff employed at your Trust’s Sexual Assault Referral Centre (SARC) for the years 2010 – 2024.

b) The number of children aged under 18 years old who have been received support by your Trust’s SARC between the years 2010 – 2024 and, if possible, the number of these who are identified as having been victims of gang-based CSE.

c) The number of victims of CSE who received mental health support from your trust between 2018 and 2024.

d) The number of children identified by your Trust as requiring safeguarding measures as a result of CSE between the years 2010 and 2024.

This should not exceed any cost limits you may have but should you, for whatever reason, decide that it does, the please proceed with parts a – c.

(1) Has your Trust procured any pancreatic enzyme replacement therapy (PERT) products from overseas suppliers between January 2023 and present? Please respond with yes or no. If yes, please answer the following: (a) Which countries were these products sourced from? (b) How many ‘special order’ prescriptions for these products have been dispensed? (c) What percentage of the local demand has been covered by these overseas products?

I would like to please request information relating to the following question –

1. In the last 12 months, how many unique patients in your trust were treated with the following products:

A) Curosurf
B) Peyona

I would like to submit an FOI request for the following data for Gloucestershire Health and Care NHS Foundation Trust:
• The number of patients treated for Dravet syndrome in 2024, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The number of patients treated for Dravet syndrome in 2025, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The number of patients treated for Lennox-Gastaut syndrome in 2024, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The number of patients treated for Lennox-Gastaut syndrome in 2025, ideally separated by month, or quarter
o Patient numbers segmented by age:
 0-3 years old
 4-8 years old
 9-18 years old
 18 years+
• The above data separated by treatment, focusing on the following treatments:
o fenfluramine
o sodium valproate
o stiripentol
o clobazam
o cannabidiol
o levetiracetam
o topiramate
o potassium bromide
o Other treatments
 carbamazepine
 gabapentin
 lacosamide
 lamotrigine
 oxcarbazepine
 phenobarbital
 pregabalin
 tiagabine
 vigabatrin
 rufinamide
• Numbers of patients moving from one specific treatment to another e.g. fenfluramide gains from cannabidiol, sodium valproate losses to cannabidiol
• Alternatively, just the numbers of patients on each treatment for each month/quarter will be able to show how the numbers on each treatment are changing

Under the Freedom of Information Act 2000, I would be grateful if you could provide the following information:
1. Adherence to National Guidelines
Does your Trust currently follow any of the following national guidelines for the treatment and management of Overactive Bladder (OAB)? Please indicate “Yes” or “No” for each of the following:
a) NICE Interventional Procedure Guidance on sacral nerve stimulation for urge incontinence and urgency-frequency (IPG64)
b) NICE Clinical Guideline on Urinary Incontinence in Women (CG171)
c) NICE Clinical Guideline on Lower Urinary Tract Symptoms in Men (CG97)
d) Any NHS England-issued clinical guidelines related to OAB management
2. Locally Adopted Guidelines
For any of the above guidelines that your Trust follows, please provide the title, version number, and date of the current guidance or policy document in use.
3. Local Protocols or Deviations
If your Trust does not follow one or more of the national guidelines listed above, or has developed local clinical pathways or protocols for the management of OAB, please provide a copy of the relevant local policy or a summary of the key differences compared to national guidance.

Under the Freedom of Information Act 2000, I would like to request the following information:
1. For each of the last five years (or as many years as data is available), please provide:
o The total number of patients recorded on the urgent referral cancer treatment pathway.
o The number of these patients whose waiting time was stopped due to an enabling treatment, as defined in the National Cancer Waiting Times Monitoring Dataset Guidance.
2. If available without exceeding cost limits, please also provide a breakdown by:
o Type of enabling treatment used (e.g., stent, dental treatment, or any others as set out in National Cancer Waiting Times Monitoring Dataset Guidance)

I am writing to request information under the Freedom of Information Act 2000.
You are receiving this request as it is believed you operate an NHS-run SARC or provide a SARC service on behalf of the NHS.

The information being requested is contained in the attached Microsoft Word document.

Please can you provide the following:

By site location(s) within the trust:

Do you have a Decontamination Lead(s)?
What is their name(s), and what is their NHS email address?

Do you have an Infection Control Lead(s)?
What is their name(s), and what is their NHS email address?

Do you have a Sterile Services Manager(s)?
What is their name(s), and what is their NHS email address?

Do you have an Endoscopy Decontamination Manager(s)?
What is their name(s), and what is their NHS email address?

Do you have an Estates Manager(s) in charge of Decontamination Equipment Validation?
What is their name(s), and what is their NHS email address?

The recent Supreme Court ruling in ‘For Women Scotland vs The Scottish Ministers’, clarified the meaning of ‘sex’ in the Equality Act 2010 as ‘biological sex’. The Equality and Human Rights Commission states:

‘This means that, under the Act:
A ‘woman’ is a biological woman or girl (a person born female) A ‘man’ is a biological man or boy (a person born male) If somebody identifies as trans, they do not change sex for the purposes of the Act, even if they have a Gender Recognition Certificate (GRC).
A trans woman is a biological man
A trans man is a biological woman’

Please set out what action(s) you have taken in your NHS Trust to ensure that each of the following aligns with the Supreme Court ruling and, in consequence, with the Equality Act 2010:

1) Gender reassignment and/or transgender guidance and policies relating to staff
2) Gender reassignment and/or transgender guidance and policies relating to patients
3) Policies on same sex accommodation
4) Related Equality Impact Assessments

I am submitting this request, on behalf of myself, under the Freedom of Information Act and the Code of Practice on Openness in the NHS. Please confirm the Trust holds the following data, and where it is held please provide the data. Please use the attached spreadsheet if possible.

1. Does your trust provide a chronic pain service? (Yes/No)
If no, this is the end of our request.

If yes, and the service is consultant-led, please provide:
2. Please confirm that the Trust submits RTT data for this service (yes/no)
3. Please confirm that the Trust submits WLMDS data for this service (yes/no)
4. Please supply the Trust’s RTT submission for every month between April 2024 and April 2025 (inclusive), but please only show data for TFC 191 – Pain Management. This data is available in the public domain but it is supplied aggregated with other specialities in category: ‘X02 – Other – Medical Services’. We are requesting it be disaggregated from this category. Please share this in the format that you have it.
5. Only if the data requested in #4 is unavailable, please provide the data requested in 5a-e for every month between April 2024 and April 2025:
5a. The number of people on the waiting list, as of the first day of the month
5b. The average waiting time in weeks
5c. The distribution of waiting times, as of the first day of the month (see suggested breakdown in the attached spreadsheet)
5d. Number of clock starts during the month
5e. Number of clock stops during the month for treatment, broken down by reason
5f. Number of clock stops during the month for non-treatment, broken down by reason
6. The average time between clock start and an interventional pain procedure being performed, in weeks
7. Please provide the Trust definitions used for Pain Management services for:
7a. Clock starts (e.g. referral received, referral received and validated, etc.)
7b. Clock stops for treatment (e.g. first appointment, advice given, information provided, etc.)
7c. Clock stops for non-treatment (please provide breakdown)

If yes, and the service is not consultant-led, please provide:
8. What is the clinician’s role who holds overall clinical responsibility, including governance, outcomes and quality, for the service (e.g. specialist nurse, clinical psychologist, other)? We are requesting the person’s position rather than any personal information.
9. Does the service provide interventional pain procedures, such as injections? (Yes/No)
9a. If yes, please provide the clinician’s role that performs them (e.g. consultant in pain medicine)? We are requesting the person’s position rather than any personal information.
9b. If no, where do you refer patients requiring interventional pain procedures to?
10. Please provide the following data for the non-consultant-led Pain Management service for every month between April 2024 and April 2025 (inclusive):
10a. The number of people on the waiting list at the first day of the month
10b. The average waiting time in weeks
10c. The distribution of waiting times, as of the first day of the month (see suggested breakdown in the attached spreadsheet)
10d. The number of new referrals during the month
10e. The number of patients who started treatment during the month (i.e. had their first appointment)
10f. The number of patients discharged without treatment (i.e. rejected referrals)

I wish to make a freedom of information request and would be grateful if you could provide the following information:

The number of referrals made by your NHS Trust to other authorities – such as the police or social services – when there was a suspicion that a child is a victim of exploitation (sexual, criminal, gang-based grooming) for the years 2010 (or earliest available year of data) – 2024 inclusive.

The number of risks assessments conducted on children where there was concern that the had been the victim of child sexual exploitation (using the same timeframe as above).

Details of your NHS Trusts’ CSE safeguarding arrangements, including work in multi-agency partnerships.

The number of staff employed by your NHS Trust who have received training on CSE.

I’m writing under the Freedom of Information Act 2000 to request information about reports of bullying and racism/racial discrimination amongst midwives working at your trust.

From 1 Jan 2020 up to and including 6 May 2025, can you please tell me the following:

1) How many reports of bullying have been made by midwives against other midwives (including student midwives on placement) at your trust? Please provide the outcomes of these.

2) How many reports of racism or racial discrimination have been made by midwives against other midwives (including student midwives on placement) at your trust? Please provide the outcomes of these.

3) Have there been any dismissals in light of bullying reports? If so, when were these? Please provide the year.

4) Have there been any dismissals in light of racism or racial discrimination reports? If so, when were these? Please provide the year.

If this request is at risk of triggering the s12 cost exemption, please advise us on how we can amend the wording of our request to align with the trust’s categorisation and/or filing conventions.